메뉴 건너뛰기




Volumn 30, Issue 1, 2011, Pages 1-4

Targeted cancer therapies

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CHINA; DRUG EFFICACY; DRUG TARGETING; EDITORIAL; EXPERIMENTAL MODEL; HUMAN; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; NONHUMAN; PATIENT IDENTIFICATION; PATIENT SELECTION;

EID: 79954603808     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10553     Document Type: Editorial
Times cited : (65)

References (3)
  • 1
    • 74549207384 scopus 로고    scopus 로고
    • The cross-validated adaptive signature design [J]
    • Freidlin B, Jiang W, Simon R. The cross-validated adaptive signature design [J]. Clin Cancer Res, 2010,16(2):691-698.
    • (2010) Clin Cancer Res , vol.16 , Issue.2 , pp. 691-698
    • Freidlin, B.1    Jiang, W.2    Simon, R.3
  • 2
    • 69949162760 scopus 로고    scopus 로고
    • Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma [J]
    • Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma [J]. N Engl J Med, 2009,361 (10):947-957.
    • (2009) N Engl J Med , vol.361 , Issue.10 , pp. 947-957
    • Mok, T.S.1    Wu, Y.L.2    Thongprasert, S.3
  • 3
    • 77953143235 scopus 로고    scopus 로고
    • Targeted cancer therapies [J]
    • Aggarwal S. Targeted cancer therapies [J]. Nat Rev Drug Discov, 2010,9(6):427-428.
    • (2010) Nat Rev Drug Discov , vol.9 , Issue.6 , pp. 427-428
    • Aggarwal, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.